AC IMMUNE SA (ACIU) Stock Earnings & Estimates
USA - NASDAQ:ACIU - CH0329023102 - Common Stock
2.46 USD
-0.08 (-3.15%)
2.46 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.9M | 14.801M 279.51% | 27.309M 84.51% | 4.1M -84.99% | 46.042M 1,022.98% | 103.69M 125.21% | 151.18M 45.80% | 251.87M 66.60% | 272.36M 8.14% | |
| EBITDA YoY % growth | -68.44M 10.64% | -51.409M 24.88% | -50.216M 2.32% | 16.32M 132.50% | -80.274M -591.88% | -85.068M -5.97% | -80.613M 5.24% | N/A | N/A | |
| EBIT YoY % growth | -70.8M 10.38% | -53.624M 24.26% | -52.378M 2.32% | -79.917M -52.58% | -41.352M 48.26% | 11.312M 127.36% | 106.36M 840.24% | 156.69M 47.32% | 165.76M 5.79% | |
| Operating Margin | -1,815.38% | -362.30% | -191.80% | -1,949.19% | -89.81% | 10.91% | 70.35% | 62.21% | 60.86% | |
| EPS YoY % growth | -0.85 14.05% | -0.64 24.71% | -0.52 18.75% | -0.78 -49.91% | -0.42 46.52% | 0.09 122.12% | 0.54 490.44% | 1.53 180.42% | 1.61 5.37% |
All data in CHF
| Q3 / 25 | Q4 / 25 | |
|---|---|---|
| EPS Q2Q % growth | -0.19 -489.95% | -0.20 -23.98% |
| Revenue Q2Q % growth | 829.556K -96.74% | 1.068M -6.07% |
| EBITDA Q2Q % growth | N/A | N/A |
| EBIT Q2Q % growth | -20.659M -384.20% | -20.956M -12.56% |
All data in CHF
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.21 8.70% | -0.18 | -0.03 | -18.00% |
| Q1 2025 Q2Q % growth | -0.19 -5.56% | -0.21 | 0.02 | 9.14% |
| Q4 2024 Q2Q % growth | -0.16 -220.00% | -0.19 | 0.03 | 16.28% |
| Q3 2024 Q2Q % growth | 0.05 127.78% | -0.20 | 0.25 | 125.04% |
| Q2 2024 Q2Q % growth | -0.23 -15.00% | 0.27 | -0.50 | -183.77% |
| Q1 2024 Q2Q % growth | -0.18 14.29% | -0.14 | -0.04 | -30.60% |
| Q4 2023 Q2Q % growth | -0.05 78.26% | -0.12 | 0.07 | 56.75% |
| Q3 2023 Q2Q % growth | -0.18 -12.50% | 0.03 | -0.21 | -787.46% |
| Q2 2023 Q2Q % growth | -0.20 13.04% | -0.20 | 0.00 | 0.63% |
| Q1 2023 Q2Q % growth | -0.21 8.70% | -0.23 | 0.02 | 10.29% |
| Q4 2022 Q2Q % growth | -0.23 17.56% | -0.26 | 0.03 | 10.53% |
| Q3 2022 Q2Q % growth | -0.16 27.27% | -0.25 | 0.09 | 35.13% |
| Q2 2022 Q2Q % growth | -0.23 11.54% | -0.24 | 0.01 | 2.94% |
| Q1 2022 Q2Q % growth | -0.23 | -0.23 | 0.00 | -1.78% |
| Q4 2021 Q2Q % growth | -0.28 -3.33% | 0.10 | -0.38 | -367.77% |
| Q3 2021 Q2Q % growth | -0.22 8.33% | -0.28 | 0.06 | 20.70% |
| Q2 2021 Q2Q % growth | -0.26 -18.18% | -0.25 | -0.01 | -6.07% |
| Q1 2021 Q2Q % growth | -0.23 -109.09% | -0.24 | 0.01 | 2.18% |
| Q4 2020 Q2Q % growth | -0.27 3.57% | -0.25 | -0.02 | -7.07% |
| Q3 2020 Q2Q % growth | -0.24 -196.00% | -0.25 | 0.01 | 4.74% |
| Q2 2020 Q2Q % growth | -0.22 8.33% | -0.25 | 0.03 | 12.58% |
| Q1 2020 Q2Q % growth | -0.11 -111.46% | -0.15 | 0.04 | 24.76% |
| Q4 2019 Q2Q % growth | -0.28 | -0.22 | -0.06 | -24.78% |
| Q3 2019 Q2Q % growth | 0.25 | 0.17 | 0.08 | 44.18% |
| Q2 2019 Q2Q % growth | -0.24 | -0.22 | -0.02 | -6.95% |
| Q1 2019 Q2Q % growth | 0.96 | 1.23 | -0.27 | -22.00% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 1.306M 90.10% | 2.02M | -714K | -35.35% |
| Q1 2025 Q2Q % growth | 990K | 329.644K | 660.356K | 200.32% |
| Q4 2024 Q2Q % growth | 1.137M -92.32% | 756.932K | 380.068K | 50.21% |
| Q3 2024 Q2Q % growth | 25.485M | 1.514M | 23.971M | 1,583.29% |
| Q1 2024 Q2Q % growth | 5.433M | -5.433M | -100.00% | |
| Q4 2023 Q2Q % growth | 14.801M | 10.234M | 4.567M | 44.63% |
| Q3 2023 Q2Q % growth | -100.00% | 21.624M | -21.624M | -100.00% |
| Q2 2023 Q2Q % growth | 1.7M | -1.7M | -100.00% | |
| Q4 2022 Q2Q % growth | 1.632M | -1.632M | -100.00% | |
| Q3 2022 Q2Q % growth | 3.93M | 237.997K | 3.692M | 1,551.28% |
| Q2 2022 Q2Q % growth | 237.997K | -237.997K | -100.00% | |
| Q1 2022 Q2Q % growth | 237.997K | -237.997K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | 28.662M | -28.662M | -100.00% |
| Q3 2021 Q2Q % growth | -100.00% | 1.782M | -1.782M | -100.00% |
| Q2 2021 Q2Q % growth | -100.00% | 1.456M | -1.456M | -100.00% |
| Q1 2021 Q2Q % growth | -100.00% | 3.448M | -3.448M | -100.00% |
| Q4 2020 Q2Q % growth | 940K 91.84% | 1.324M | -384K | -29.00% |
| Q3 2020 Q2Q % growth | 1.12M -96.65% | 867K | 253K | 29.18% |
| Q2 2020 Q2Q % growth | 1.28M -15.23% | 510K | 770K | 150.98% |
| Q1 2020 Q2Q % growth | 12.41M -83.46% | 13.107M | -697K | -5.32% |
| Q4 2019 Q2Q % growth | 490K | 11.485M | -10.995M | -95.73% |
| Q3 2019 Q2Q % growth | 33.41M | 31.79M | 1.62M | 5.10% |
| Q2 2019 Q2Q % growth | 1.51M | 1.19M | 320K | 26.89% |
| Q1 2019 Q2Q % growth | 75.04M | 100.06M | -25.02M | -25.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.71% | 3.37% | 0.41% | 4.81% |
| Revenue | 159.6% | 159.6% | 12.08% | 12.08% |